NissensonA.R., KorbetS., FaberM., BurkartJ., GentileD., HamburgerR.Multicenter trial of erythropoietin in patients on peritoneal dialysis.J Am Soc Nephrol1995; 5: 1517–29.
2.
BárányP., ClyneN., HylanderB., JohanssonA.C., SimonsenO., LarssonR.Subcutaneous epoetin beta in renal anemia: An open multicenter dose titration study of patients on continuous peritoneal dialysis.Perit Dial Int1995; 15: 54–60.
3.
FallerB., SlingeneyerA., WallerM., MichelC., GrutzmacherP., MullerH.P.Daily subcutaneous administration of recombinant human erythropoietin (rhEPO) in peritoneal dialysis patients: A European dose-response study.Clin Nephrol1993; 40: 168–75.
4.
EschbachJ.W., KellyM.R., HaleyN.R., AbelsR.I., AdamsonJ.W.Treatment of anemia of progressive renal failure with recombinant human erythropoietin.N Engl J Med1989; 321: 158–63.
5.
AkmalM., SawelsonS., KarubianF., GadallahM.The prevalence and significance of occult blood loss in patients with predialysis advanced chronic renal failure (CRF), or receiving dialytic therapy.Clin Nephrol1994; 42: 198–202.
6.
MeansR.T., KrantzS.B.Progress in understanding the pathogenesis of the anemia of chronic disease.Blood1992; 80: 1639–47.
7.
MilmanN.Iron therapy in patients undergoing maintenance hemodialysis.Acta Med Scand1976; 200: 315–19.
8.
GokalR., MillardP.R., WeatherallD.J., CallenderS.T.E., LedinghamJ.G.G., OliverD.O.Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload.Q J Med1979; 48: 369–91.
9.
DonnellyS.M., PosenG.A., AliM.A.Oral iron absorption in hemodialysis patients treated with erythropoietin.Clin Invest Med1991; 14: 271–6.
10.
KochK.M., PatynaW.D., ShaldonS., WernerE.Anemia of the regular hemodialysis patient and its treatment.Nephron1974; 12: 405–19.
11.
SkikneB., AhluwaliaN., FergussonB., ChonkoA., CookJ.Effects of recombinant human erythropoietin on iron absorption in chronic renal failure (Abstract).Blood1998; 92: 24B.
12.
GoodnoughL.T., SkikneB., BrugnaraC.Erythropoietin, iron, and erythropoiesis.Blood2000; 96: 823–33.
13.
TinawiM., MartinK.J., BastaniB.Oral iron absorption test in patients on CAPD: Comparison of ferrous sulfate and a polysaccharide ferric complex.Nephron1996; 74: 291–4.
14.
MacDougallI.C., TuckerB., ThompsonJ., TomsonC.R.V., BakerL.R.I., RaineA.E.G.A randomized controlled study of iron supplementation in patients treated with erythropoietin.Kidney Int1996; 50: 1694–9.
15.
KooistraM.P., MarxJ.M.M.The absorption of iron is disturbed in recombinant human erythropoietin-treated peritoneal dialysis patients.Nephrol Dial Transplant1998; 13: 2578–82.
16.
MarsR.L., MolesK., PopeK., HargroveP.Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.Adv Perit Dial1999; 15: 60–4.
17.
VychytilA., Haag–WeberM.Iron status and iron supplementation in peritoneal dialysis patients.Kidney Int Suppl1999; 69: S71–8.
18.
WingardR.L., ParkerR.A., IsmailN., HakimR.Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin.Am J Kidney Dis1995; 25: 433–9.
19.
AhsanN.Intravenous infusion of total dose iron is superior to oral iron in treatment of anemia in peritoneal dialysis patients: A single center comparative study.J Am Soc Nephrol1998; 9: 664–8.
20.
DittrichE., PuttingerH., SchneiderB., HörlW.H., Haag–WeberM., VychytilA.Is absorption of high-dose oral iron sufficient in peritoneal dialysis patients.Perit Dial Int2000; 20: 667–73.
21.
BastaniB., IslamS., BoroujerdiN.Iron absorption after single pharmacological oral iron loading test in patients on chronic peritoneal dialysis and in healthy volunteers.Perit Dial Int2000; 20: 662–6.
22.
MilmanN.Iron absorption measured by whole body counting and the relationship to marrow iron stores in chronic uremia.Clin Nephrol1982; 17: 77–81.
23.
RalphB., ToffelmireE.B.Adverse effects of ferrous gluconate prescribed in split doses compared to a single bedtime dose in hemodialysis patients (Abstract).Clin Pharmacol Ther1995; 57: 219.
